Table 2.
Number of human studies about the association between urinary concentration of oxybenzone (BP-3) or octinoxate (OMC) and the physiological outcomes. n=16 (duplicate excluded)
| Target effect | Statistically significant association |
No statistically significant association |
||
|---|---|---|---|---|
| BP-3 | OMC | BP-3 | OMC | |
| Thyroid hormone level | 2 (↓↓) | 0 | 3 | 1a |
| Pubertal onset | 2 (↓↑) | 0 | 0 | 0 |
| Male reproductive hormone level | 1 (↓) | 0 | 1 | 1a |
| Female reproductive hormone level | 0 | 0 | 2 | 1a |
| Kidney function | 1 (↓) | 0 | 0 | 0 |
| Fertility | 0 | 0 | 4 | 0 |
| Childhood adiposity | 0 | 0 | 1 | 0 |
In parenthesis, ↓ indicates a negative correlation with elevated BP-3 level. ↑ indicates a positive correlation with elevated BP-3 level.
The results are from the same paper that is also included in BP-3 column.